ELVN icon

Enliven Therapeutics

61 hedge funds and large institutions have $534M invested in Enliven Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

33% less capital invested

Capital invested by funds: $798M → $534M (-$264M)

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$151K
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$65K
52
$45.7K
53
$31K
54
$27.3K
55
$26.3K
56
$17.5K
57
$7.73K
58
$1.43K
59
$683
60
$123
61
62
63
64
65
66
67
68